Although circulating RBP4 levels were not associated with NAFLD overall, the results of subgroup analysis suggested that RBP4 levels were significantly higher in NAFLD patients who were diagnosed by ultrasound techniques compared with the controls. The gene discussed is RBP4; the disease is metabolic dysfunction-associated steatotic liver disease.